細胞培養市場規模、佔有率及成長分析（按應用、最終用戶、產品及地區分類）－2026-2033年產業預測

2024 年全球細胞培養市場規模為 287.6 億美元，預計到 2033 年將達到 796.2 億美元，而 2025 年為 322 億美元，在預測期（2026-2033 年）內複合年成長率為 11.98%。

由於細胞培養技術在製藥和生物技術領域的重要應用，全球細胞培養市場正經歷顯著成長。推動這一成長的關鍵因素包括：慢性病和老齡化人口的增加，以及對先進治療方案的需求不斷成長，從而帶動了生物製藥需求的持續成長。細胞培養技術是生物製藥生產的基礎，尤其是在製藥公司專注於標靶治療和精準醫療的背景下。此外，將基於細胞的檢測方法整合到藥物篩檢和研發中，也增強了藥物發現能力。創新和持續的研發投入正在改變產業格局，而人們對細胞培養技術應用和技術進步的認知不斷提高，也正在推動市場成長。北美和歐洲憑藉其強大的研究基礎設施和對醫療保健領域的大量投資，在市場佔有率方面佔據主導地位。

全球細胞培養市場按產品、應用、最終用戶和地區進行細分。按產品分類，可分為耗材和設備。按應用分類，可分為生物製藥生產、診斷、組織工程和再生醫學、藥物篩檢和開發以及其他應用。按最終用戶分類，可分為製藥和生物技術公司、醫院和診斷實驗室、研究和學術機構以及其他最終用戶。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球細胞培養市場促進因素

全球細胞培養市場主要受生物製藥領域持續創新的驅動。對包括單株抗體和疫苗在內的先進生物治療方法的需求不斷成長，對高效的細胞培養技術提出了更高的要求。隨著生物製藥產業積極擁抱精準醫療和標靶治療，細胞培養對於這些複雜藥物的生產至關重要，因此市場正在不斷擴張。此外，尖端生物製程技術的整合、創新細胞培養基系統的開發以及用於改進生物藥物生產的配套基礎設施的建設，也都在促進這一成長，共同推動市場的發展。

全球細胞培養市場面臨的限制因素

由於嚴格的監管要求和對高品質品管措施的需求，全球細胞培養市場面臨許多挑戰。生物製藥和各種細胞產品的生產必須符合嚴格的安全性、有效性和一致性標準。這需要遵循良好生產規範 (GMP) 以及詳盡的文件記錄和檢驗流程。此外，對於市場參與企業，尤其是希望推出新產品的中小企業 (SME) 而言，應對複雜的監管合規流程可能尤其困難。這些障礙可能會抑制創新，並限制整個細胞培養產業的成長潛力。

全球細胞培養市場趨勢

全球細胞培養市場的一個顯著趨勢是3D細胞培養技術的日益普及。與傳統的2D培養相比，3D培養能夠顯著提高體外模型的生理相關性。這一轉變的驅動力源於藥物研發和個人化醫療領域對高預測性模型的日益成長的需求，研究人員希望更精確地模擬人體組織和疾病的複雜性。此外，生物材料和支架技術的進步也使得細胞生長和分化更有效率，進一步拓展了3D培養在製藥、生物技術和再生醫學領域的應用範圍。最終，向3D培養的轉變體現了業界對創新的執著追求和改善治療效果的決心。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 案例研究

全球細胞培養市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 消耗品
  • 血清、培養基和試劑
  • 培養基
  • 試劑
  • 血清
  • 容器
  • 細胞培養系統/細胞堆
  • 滾輪/屋頂瓶
  • 燒瓶
  • 多孔孔盤
  • 培養皿
• 配件

全球細胞培養市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 生物製藥生產
  • 單株抗體生產
  • 疫苗生產
  • 其他治療性蛋白質的生產
• 診斷
• 組織工程與再生醫學
  • 細胞和基因治療
  • 其他組織工程及再生醫學應用
• 藥物篩檢與開發
• 其他用途

全球細胞培養市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥和生物技術公司
• 醫院和診斷檢查室
• 研究和學術機構
• 其他最終用戶

全球細胞培養市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.（US）
• Danaher Corporation（US）
• Merck KGAA（Germany）
• Sartorius AG（Germany）
• Corning Incorporated（US）
• Fujifilm Holdings Corporation（Japan）
• BD（Becton, Dickinson and Company）（US）
• Eppendorf SE（Germany）
• Lonza（Switzerland）
• Getinge AB（Sweden）
• Agilent Technologies, Inc.（US）
• Himedia Laboratories（India）
• Bio-Techne（US）
• Miltenyi Biotec（Germany）
• Stemcell Technologies（Canada）
• Solida Biotech GmbH（Germany）
• Caisson Labs Inc.（US）
• Promocell GmbH（Germany）
• Invivogen（US）
• Pan-Biotech（Germany）

結論與建議

Global Cell Culture Market size was valued at USD 28.76 Billion in 2024 and is poised to grow from USD 32.2 Billion in 2025 to USD 79.62 Billion by 2033, at a CAGR of 11.98% during the forecast period (2026-2033).

The global cell culture market is experiencing significant growth driven by its vital applications in pharmaceuticals and biotechnology. Key factors fueling this expansion include the increasing demand for biopharmaceuticals, driven by rising chronic diseases and an aging population, necessitating advanced therapeutic solutions. Cell culture serves as a cornerstone in biopharmaceutical manufacturing, particularly as pharmacological companies focus on targeted therapies and precision medicine. Furthermore, the integration of cell-based tests into drug screening and development enhances the capability for drug discovery. Innovation and ongoing R&D investments are transforming the landscape, while heightened awareness of cell culture applications and advancements in technology are propelling market growth. North America and Europe lead in contributions, backed by robust research infrastructures and substantial health sector investments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Market Segments Analysis

The global cell culture market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Equipment. Based on Application, the market is segmented into Biopharmaceutical Production, Diagnostics,Tissue Engineering& Regenerative Medicine, Drug Screening & Development, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Other End Users. Based on region, the cell culture market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Culture Market

The global cell culture market is significantly propelled by continuous innovations within the biopharmaceutical sector. The growing demand for advanced biotherapies, including monoclonal antibodies and vaccines, necessitates efficient cell culture techniques. As the biopharmaceutical industry embraces precision medicine and targeted therapies, the market expands due to the reliance on cell culture for the production of these complex drugs. Additionally, the integration of cutting-edge bioprocessing technologies and the development of innovative cell culture media systems contribute to this growth, as do supportive infrastructures aimed at enhancing the production of biological pharmaceuticals, collectively driving the market's upward trajectory.

Restraints in the Global Cell Culture Market

The Global Cell Culture market faces considerable challenges due to strict regulatory requirements and the necessity for high-quality control measures. The production of biopharmaceuticals and various cell-based products must adhere to stringent safety, efficacy, and consistency standards. This compliance requires extensive documentation and validation processes, along with adherence to Good Manufacturing Practices (GMP). Moreover, navigating the complexities of regulatory compliance can be particularly daunting for market participants, especially smaller companies seeking to introduce new products. These hurdles hinder innovation and may limit the overall growth potential within the cell culture sector.

Market Trends of the Global Cell Culture Market

A notable trend in the global cell culture market is the increasing adoption of 3D cell culture technologies, which enhance the physiological relevance of in vitro models compared to traditional 2D cultures. This shift is driven by the growing demand for more predictive models in drug development and personalized medicine, as researchers seek to better mimic the complexities of human tissues and diseases. Additionally, advancements in biomaterials and scaffolding techniques are facilitating more effective cell growth and differentiation, further expanding applications across pharmaceuticals, biotechnology, and regenerative medicine. Ultimately, the move towards 3D cultures reflects the industry's commitment to innovation and improved therapeutic outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Case Studies

Global Cell Culture Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Sera, Media, And Reagents
  • Media
  • Reagents
  • Sera
  • Vessels
  • Cell factory systems/cell stacks
  • Roller/roux bottles
  • Flasks
  • Multiwell plates
  • Petri dishes
• Accessories

Global Cell Culture Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Production
  • Monoclonal Antibody Production
  • Vaccine Production
  • Other Therapeutic Protein Production
• Diagnostics
• Tissue Engineering & Regenerative Medicine
  • Cell & Gene Therapy
  • Other Tissue Engineering & Regenerative Medicine Applications
• Drug Screening & Development
• Other Applications

Global Cell Culture Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Other End Users

Global Cell Culture Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGAA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solida Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caisson Labs Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promocell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invivogen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pan-Biotech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations